{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":26,"n_cols":5,"rows_kept":26,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[3,2,3,3],[12,2,12,3],[13,2,13,3],[14,2,14,3],[16,2,16,3],[17,2,17,3],[21,2,21,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9911020258803321"]
[null,null,"Titolo",null,"Heart failure : pharmacologic management / / edited by Arthur M. Feldman"]
[null,null,"Pubbl/distr/stampa",null,"Oxford, : Blackwell Futura, 2006"]
[null,null,"ISBN",null,"9786610743193"]
[{"$nulls":4},"9781280743191"]
[{"$nulls":4},"1280743190"]
[{"$nulls":4},"9780470794807"]
[{"$nulls":4},"0470794801"]
[{"$nulls":4},"9780470994740"]
[{"$nulls":4},"0470994746"]
[{"$nulls":4},"9781405172530"]
[{"$nulls":4},"1405172533"]
[null,null,"Descrizione fisica",null,"1 online resource (306 p.)"]
[null,null,"Disciplina",null,"616.129061"]
[null,null,"Soggetti",null,"Congestive heart failure - Chemotherapy"]
[{"$nulls":4},"Heart"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references."]
[null,null,"Nota di contenuto",null,"Heart Failure: Pharmacologic Management; Contents; Contributors; Introduction; 1 Diuretics in congestive heart failure; 2 Use of digoxin in the treatment of heart failure; 3 Renin-angiotensin system and angiotensin converting enzyme inhibitors in chronic heart failure; 4 Angiotensin receptor blockers in the treatment of heart failure; 5 Beta blockers; 6 Aldosterone antagonism in the pharmacological management of chronic heart failure; 7 Inotropic therapy in clinical practice; 8 Antiarrhythmic therapy in heart failure"]
[{"$nulls":4},"9 Treating the hypercoagulable state of heart failure: modifying the risk of arterial and venous thromboembolism10 Vasodilator and nitrates; 11 Natriuretic peptides for the treatment of heart failure; 12 Immune modulatory therapies in heart failure: using myocarditis to gain mechanistic insights; 13 The role of vasopressin and vasopressin antagonists in heart failure; 14 Role of erythropoietin in the correction of anemia in patients with heart failure; 15 Endothelin antagonism in cardiovascular disease; 16 Pharmacogenetics; 17 Management of "]
[{"$nulls":4},"diastolic dysfunction"]
[{"$nulls":4},"18 Multidrug pharmacy for treatment of heart failure: an algorithm for the clinicianIndex"]
[null,null,null,"Sommario/riassunto","Now there is an up-to-date guide for optimizing pharmacologic therapy in treating patients with heart failure. Reflecting current practice at leading medical centers, Heart Failure: Pharmacologic Management provides both the biologic and pathologic underpinnings of each pharmacologic agent in current use. It also supplies detailed discussions of the clinical investigations that support current understanding of the risks and benefits associated with the use of these drugs. Thorough references make the book useful to the novice as well as the experienced clinician. Initial cha"]